UConn Researchers Overcome a Vexing P... - Lung Conditions C...

Lung Conditions Community Forum

55,061 members65,848 posts

UConn Researchers Overcome a Vexing Problem in Vaccine Research

2greys profile image
0 Replies

Researchers at UConn’s Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published in the Nature Partner Journal – Vaccines.

For Mycoplasma pneumoniae, vaccine development has been stalled since the 1960s due to a phenomenon called vaccine-enhanced disease (VED) or vaccine-induced disease exacerbation. A vaccine for this type of community-acquired pneumonia has been long sought, since the illness can pose problems for closed community settings such as military bases, hospitals, ships, college dormitories, and prisons.

today.uconn.edu/2020/06/uco...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Pneumonia Vaccine for the Immunosuppressed

Good afternoon everyone, I had my pneumonia vaccine many years ago, then 5 years ago before I was...

Hib Vaccine query…..😊

Hib vaccines (for use in adults who have problems with Haemophilis Influenzae and Strep...

Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults.

causes COVID-19 disease. The experimental vaccine, mRNA-1273, was co-developed by researchers at...

pneumonia vaccination

I have been told to get my pneumonia jab , i’m not worried about sore arm, but i’m just a bit...

Finding about research

to be involved in developing research questions or becoming participants in research? Is anyone...